Recombinatie CMEC2D monoklonaal antilichaam

C-type lectin domain family 2 member D (CLEC2D), also known as lectin-like transcript 1 (LLT1) and osteoclast inhibitory lectin (OCIL), is a type II transmembrane C-type lectin receptor primarily expressed upon immune cell activation in T cells, B cells, NK cells, and plasmacytoid and monocyte-derived dendritic cells. CLEC2D interacts with NKR-P1A (KLRB1, CD161) on NK cells and some subsets of T cells, inhibiting NK cell cytotoxicity while alternatively inducing proliferation and IFNγ production in T cells. CLEC2D is also expressed by osteoblasts, inhibiting osteoclast formation and bone resorption.

CLEC2D

Q9UHP7

Human

Recombinant human CLEC2D fragment

LLT; CLEC2D; CLAX; LLT1; OCIL; C type lectin related f; C type lectin superfamily 2; CLC2D; CLEC2D protein; Clec2d5; C-type lectin domain family 2 member D; L LT1; Lectin like NK cell receptor; Lectin like transcript 1; Lectin-like NK cell receptor; Lectin-like transcript 1; LLT-1; member D; Osteoclast inhibitory lectin

A686

Unconjugated

WB

Immunology

Protein A purified

1 mg/mL

WB 1:500-1:1000

PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.

Ice bag

Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.

https://789.bio/eb/OthO5FoQ

22 kDa

25-35 kDa

IgG, κ